Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT)

NCT00764725 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

487

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: conventional DMARD combination
BIOLOGICAL: MTX plus anti-TNF

Sponsor

Karolinska Institutet